Wolverine Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.09M | Buy |
50,900
+45,400
| +825% | +$2.65M | 0.03% | 449 |
|
|
2025
Q4 | $297K | Buy |
5,500
+5,200
| +1,733% | +$250K | ﹤0.01% | 1046 |
|
|
2025
Q3 | $13.5K | Sell |
300
-23,900
| -99% | -$1.12M | ﹤0.01% | 1333 |
|
|
2025
Q2 | $1.12M | Sell |
24,200
-13,900
| -36% | -$682K | 0.01% | 678 |
|
|
2025
Q1 | $2.32M | Buy |
38,100
+21,800
| +134% | +$1.27M | 0.03% | 480 |
|
|
2024
Q4 | $922K | Sell |
16,300
-4,400
| -21% | -$246K | 0.01% | 719 |
|
|
2024
Q3 | $1.07M | Hold |
20,700
| – | – | 0.01% | 681 |
|
|
2024
Q2 | $860K | Sell |
20,700
-5,000
| -19% | -$224K | 0.01% | 711 |
|
|
2024
Q1 | $1.39M | Sell |
25,700
-92,900
| -78% | -$4.73M | 0.02% | 570 |
|
|
2023
Q4 | $6.09M | Buy |
118,600
+34,300
| +41% | +$1.8M | 0.05% | 315 |
|
|
2023
Q3 | $4.89M | Sell |
84,300
-23,200
| -22% | -$1.42M | 0.05% | 320 |
|
|
2023
Q2 | $6.87M | Sell |
107,500
-31,300
| -23% | -$2.1M | 0.08% | 236 |
|
|
2023
Q1 | $9.62M | Buy |
138,800
+82,800
| +148% | +$5.84M | 0.11% | 205 |
|
|
2022
Q4 | $4.03M | Buy |
+56,000
| New | +$4.22M | 0.04% | 390 |
|
|
2019
Q1 | – | Sell |
-376,800
| Closed | -$19.6M | – | 1393 |
|
|
2018
Q4 | $19.6M | Buy |
376,800
+124,100
| +49% | +$6.67M | 0.24% | 87 |
|
|
2018
Q3 | $15.7M | Sell |
252,700
-34,500
| -12% | -$2.05M | 0.18% | 118 |
|
|
2018
Q2 | $15.9M | Buy |
287,200
+71,100
| +33% | +$3.84M | 0.21% | 106 |
|
|
2018
Q1 | $13.7M | Buy |
216,100
+58,100
| +37% | +$3.74M | 0.18% | 118 |
|
|
2017
Q4 | $9.68M | Hold |
158,000
| – | – | 0.1% | 179 |
|
|
2017
Q3 | $10.1M | Hold |
158,000
| – | – | 0.11% | 158 |
|
|
2017
Q2 | $8.8M | Sell |
158,000
-7,500
| -5% | -$408K | 0.11% | 157 |
|
|
2017
Q1 | $9M | Buy |
+165,500
| New | +$9.08M | 0.14% | 138 |
|
|
2016
Q1 | – | Sell |
-493
| Closed | -$37K | – | 1243 |
|
|
2015
Q4 | $37K | Sell |
493
-185
| -27% | -$12.2K | ﹤0.01% | 1200 |
|
|
2015
Q3 | $125K | Buy |
678
+430
| +173% | +$27.3K | ﹤0.01% | 1035 |
|
|
2015
Q2 | $8K | Hold |
248
| – | – | ﹤0.01% | 1629 |
|
|
2015
Q1 | $13K | Sell |
248
-514
| -67% | -$32.2K | ﹤0.01% | 1507 |
|
|
2014
Q4 | $32K | Sell |
762
-153
| -17% | -$8.63K | ﹤0.01% | 1517 |
|
|
2014
Q3 | $157K | Buy |
915
+39
| +4% | +$1.95K | ﹤0.01% | 1157 |
|
|
2014
Q2 | $229K | Buy |
876
+268
| +44% | +$13.2K | 0.01% | 870 |
|
|
2014
Q1 | $149K | Sell |
608
-268
| -31% | -$14.3K | ﹤0.01% | 972 |
|
|
2013
Q4 | $40K | Hold |
876
| – | – | ﹤0.01% | 1840 |
|
|
2013
Q3 | $94K | Sell |
876
-51
| -6% | -$2.24K | ﹤0.01% | 1480 |
|
|
2013
Q2 | $160K | Buy |
+927
| New | +$40.2K | ﹤0.01% | 1216 |
|
Other funds holding BMY
VCM
VPM
Wolverine Asset Management's BMY Position: Q4 2025 in Review
Wolverine Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 220 shares — an estimated $10.6K sold.
Wolverine Asset Management first reported a position in BMY in Q2 2013 and held it in 24 quarters. The position peaked at $15.2M in Q4 2018. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Wolverine Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 220 Bristol-Myers Squibb shares in Q4 2025, an estimated $10.6K.
- Wolverine Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 24 quarters.
- Wolverine Asset Management's Bristol-Myers Squibb position peaked at $15.2M in Q4 2018.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.